drugset / Trial / NCT00906204

Safety Trial of Single Versus Multiple Dose Thymoglobulin Induction in Kidney Transplantation

NCT00906204 ↗

RandomizedParallel-groupTriple-blindTreatment

Summary

In a non-blinded pilot study conducted at the University of Nebraska Medical Center, evidence was found that a single large dose of Thymoglobulin on the day of kidney transplantation produced better kidney function than the standard dosing plan, when the same amount is divided into smaller doses on 4 days. This new study repeats that dose comparison, but with double-blinding and at multiple transplantation centers.

Timeline

Start
2010-03
Primary completion
2014-07
Completion
2014-07

Outcome

Met primary endpoint

paper Interim analysis showed primary end point noninferiority of SD-rATG induction (p = 0.6), PMID 26696251 ↗

paper we have shown SD-rATG induction to be noninferior to DD-rATG induction in early tolerability PMID 26696251 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Thymoglobulin Protein / enzyme biologic 1.5 mg/kg Intravenous
Subject Thymoglobulin Protein / enzyme biologic 6 mg/kg Intravenous